Back to Results
First PageMeta Content
Levulan / Actinic keratosis / DUSA Pharmaceuticals / Photodynamic therapy / Food and Drug Administration / Fluorouracil / Actinism / Topical / Medicine / Pharmacology / Health


DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857
Add to Reading List

Open Document

File Size: 45,11 KB

Share Result on Facebook

City

Beltsville / Upton Drive Wilmington / MACMIS / Wilmington / /

Company

D. Geoffrey Shulman DUSA Pharmaceuticals Inc. / DUSA Pharmaceuticals Inc. / Topical Solution D. Geoffrey Shulman DUSA Pharmaceuticals Inc. / /

Country

United States / /

Event

FDA Phase / /

/

IndustryTerm

treatment site / /

MedicalCondition

actinic keratosis / allergies / moderately thick actinic keratoses / erythema / itching / Excessive irritation / seizure / porphyria / hyperkeratotic actinic keratoses / slightly palpable actinic keratoses / actinic keratoses / /

MedicalTreatment

Photodynamic Therapy / /

Organization

Food and Drug Administration / Division of Drug Marketing / Advertising / and Communications / DEPARTMENT OF HEALTH / Center for Drug Evaluation / /

Person

Thomas W. Abrams / /

Position

investigator / PRECAUTIONS General / BLU-U Blue Light Photodynamic Therapy Illuminator / Director / BLUU Blue Light Photodynamic Therapy Illuminator / FRCPC Chairman of the Board and Chief Executive Officer / /

Product

Levulan / griseofulvin / U Blue Light Photodynamic Therapy Illuminator / Levulan® Kerastick / /

ProvinceOrState

Maryland / Massachusetts / /

SocialTag